News 03 Apr 2024 Nouscom receives additional funding for cancer vaccines Nouscom has received an investment totalling 7 million euros from the Italian venture capital firm Angelini Ventures. The Basel-based biotech com...
News 26 Mar 2024 Top Stories from Western Switzerland (March 2024) From innovative approaches in cardiac care and sustainable plastics to enhancing spinal cord injury therapies and advancing virtual power plants,...
News 13 Dic 2023 Macrogen establishes foothold in Basel Macrogen Europe is set to move into the Novartis Campus of Switzerland Innovation Park Basel Area. As with its parent company, the South Korean b...
News 15 Nov 2023 Nouscom secures 67.5 million euros in financing Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based company intends to use the funds to advance the clinical dev...
News 19 Set 2023 Multiwave Technologies secures CHF 3.8 million for its light portable MRI device An innovator in the realm of medical imaging, Geneva-based deeptech start-up Multiwave Technologies has secured CHF 3.8 million in a dual-phase c...
News 24 Ago 2023 Nanomedicine pioneer Nanobacterie achieves remarkable patent ranking Drawing from the achievements of its parent company, Nanobacterie, Valais-based AlphaOnco Swiss stands at the forefront of innovative nanomedicin...
News 26 Apr 2023 Siegfried breaks ground on new global R&D Center for Drug Substances in Evionnaz Siegfried will create a new global R&D Center in Evionnaz, investing CHF 25 million to boost capacity, drive growth, and leading to the creation ...
News 24 Mag 2023 Latest research shows 20% of European biotechs now headquartered in Switzerland Press release New research conducted by IQVIA and recently published in the 2023 Swiss Biotech Report shows that 20% of European biotech companies are now head...
Spotlight 15 Giu 2023 Access to Ecosystem Switzerland is a global leader in biotech, medtech and pharma. Find out what makes the Swiss life science industry unique and how your life scien...
News 18 Ott 2021 Owkin heading to Basel The Franco-US start-up Owkin is establishing a branch office in Basel. The company develops solutions for the life sciences industry on the basis...
News 04 Nov 2021 INTEGRA Biosciences builds campus in Graubünden The laboratory equipment specialist INTEGRA Biosciences AG is expanding its headquarters in Zizers in the Greater Zurich Area. It plans to build ...
News 21 Lug 2021 GeNeuro raises EUR 6 million for multiple sclerosis treatment GeNeuro, a Geneva-based biopharmaceutical company developing new treatments for neurodegenerative diseases, has raised EUR 6 million through a pr...
News 03 Ott 2021 ABB, Novartis and Roche ranked among the world's most innovative firms Three Swiss firms, namely ABB, Novartis and Roche, have all made the Clarivate rankings of the 100 most innovative companies in the world. Switze...
News 16 Dic 2021 Basel alliance seeks to combat antibiotic resistance The SPEARHEAD alliance has been founded in Basel with the aim of combating the silent pandemic of antimicrobial resistance. By 2050, this will ca...
News 13 Apr 2021 Lonza to create 1,200 new jobs at its Covid-19 vaccine production site in Visp Biopharmaceutical giant Lonza has announced the creation of 1,200 new jobs for the manufacturing of Moderna’s Covid-19 vaccine on its site in Vis...
News 18 Gen 2021 Holmusk opens new office in Basel Holmusk has opened an office in Basel. The company from Singapore develops digital therapies on the basis of data analysis. Holmusk has placed a ...
Success stories 15 Apr 2020 Switzerland is an interesting playground for IBM to develop artificial intelligence IBM Switzerland This year's Swiss Biotech Report by the Swiss Biotech Association outlines a new decade - a decade in which Switzerland can rely on a compre...
News 16 Lug 2020 Basel is “probably the most productive life sciences location in the world” Two thirds of the value added attributable to the pharmaceutical industry as a whole in Switzerland is generated in the Basel Area, as revealed b...